Immunotherapy and Stereotactic Body Radiotherapy (SBRT) for Metastatic Anaplastic Thyroid Cancer

NCT03122496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Anaplastic Thyroid Cancer

Interventions

DRUG: durvalumab
DRUG: tremelimumab
RADIATION: Stereotactic Body Radiotherapy (SBRT)

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]